When BETd260, a PROTAC molecule consisting of HJB97 (warhead for BET) and thalidomide, was used to treat colorectal cancers, it stimulated the expression of death receptor 5 (DR5) and BET deficiency-mediated cell apoptosis. Here, DNER is linked to colorectal cancer.